Stereotaxis shows improved gross profit and reduced operating losses but faces substantially higher cash burn and growing receivables.
The company demonstrates operational progress with higher gross margins and reduced losses, suggesting better efficiency in its robotic medical systems business. However, the significantly higher cash burn rate raises concerns about liquidity sustainability, while growing receivables may indicate collection challenges or delayed customer payments.
Stereotaxis delivered mixed financial results with gross profit growing 17% to $17.1M and operating losses narrowing modestly to $22.1M, indicating improving operational efficiency. However, operating cash flow burned substantially more cash compared to the prior year, while accounts receivable grew notably to $5.8M. The overall picture suggests operational improvements are being offset by working capital pressures and higher cash requirements.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Operating cash flow fell 61.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Receivables surged 52.9% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Current assets grew 28% — improving short-term liquidity or inventory/receivables build.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Inventory built 14.8% — monitor whether demand supports this build or if write-downs may follow.
Asset base grew 11.8% — expansion through organic growth, acquisitions, or capital deployment.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →